The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I just put money into their 6.2% savings bond before it was pulled...
Are they going bust? the share price is suggesting that. at least my money is covered by the 85k protection scheme if they are going to the wall. Wish I hadn`t kept the shares though
UK Looks at QE Change to Avert £10 Billion Payout to Banks
Truss adviser says government has looked at reserves tiering
Policy would amount to ‘stealth tax’ on banks, industry says
https://www.bloomberg.com/news/articles/2022-09-21/uk-looks-at-qe-change-to-avert-10-billion-payout-to-banks?srnd=premium-uk
Hopefully a bounce tomorrow..
Liz Truss: No windfall tax on energy companies
Liz Truss on Thursday night rejected calls to increase the windfall tax on energy companies to fund cost of living handouts for households, saying profit is not a “dirty word”.
The Foreign Secretary said she was “absolutely” against such taxes, arguing that such a policy approach would be taken by Labour.
Haleon PLC - Statement re Zantac
11 August 2022 22:20
WEYBRIDGE, UK / ACCESSWIRE / August 11, 2022 / Haleon plc (LSE:HLN) notes the
recent volatility in its share price and is aware of market speculation on
Haleon's potential liability in respect of Zantac product liability
litigation.
· Haleon is not aware of any material developments in relation to the Zantac
litigation since the Haleon prospectus was issued on 1 June 2022.
· Haleon is not a party to any of the Zantac claims.
· Haleon never marketed Zantac in any form in the U.S.
· Haleon is not primarily liable for any OTC or prescription claims.
· To the extent GSK and/or Pfizer are held liable in respect of OTC Zantac
during the periods outlined below, Haleon may be required to indemnify GSK
and/or Pfizer, only if the following conditions are met:
o GSK and/or Pfizer are unable to recover in respect of OTC Zantac from any
third parties who are ahead of Haleon and who have given indemnities under
previous transfers of rights to OTC Zantac; and
o Haleon is determined to be liable under the indemnification provisions among
Haleon, Pfizer and GSK.
Haleon not a party to U.S. litigation focused on Zantac – spokesperson
11 August 2022 12:23
LONDON, Aug 11 (Reuters) – Haleon – GSK's recently spun off consumer health unit – is not a party to the U.S. litigation focused on the heartburn medicine Zantac, a spokesperson told Reuters on Thursday.
"We have never marketed Zantac in any form in the U.S., as Haleon or as GSK consumer healthcare," the spokesperson said in response to queries about sharp declines in Haleon shares.
Given over-the-counter Zantac has been sold by several companies over time, that "may make third parties liable ahead of any Haleon exposure," the spokesperson added.
hmm I misjudged this one but think it looks way overdone so will hold...we`ve now lost 18% nearly 3 billion in less than 48 hours and £27 billion lower than Unilever`s takeover offer...is this Zantac issue really going to be that bad it destroys the company...